ARTICLES
-
-
Year
-
-
- Practices
-
Chinese Mainland Capital MarketsHong Kong & Overseas Capital MarketsInvestment/M&A & Corporate GovernanceCross-border Investment/M&AConstruction & Project DevelopmentFinancingDebt Restructuring & Non-performing AssetsTaxation & Wealth PlanningPrivate Equity & Investment FundsFinancial Products & TrustsLitigation & ArbitrationCorporate & Commercial CrimeBankruptcy, Insolvency & ReorganizationShippingCompliance & InvestigationAntitrust & CompetitionTrade Compliance & Trade RemediesCustoms & Import/ExportLabor & EmploymentHealth, Safety & Environmental ProtectionIP Licensing & EnforcementTrademark ProsecutionPatent ProsecutionCybersecurity & Data Protection
-
- Industries
-
Real EstateUrban InfrastructureTransportation & LogisticsTourism & HospitalityEnergy & PowerMining & Natural ResourcesBanking & Financial ServicesInsuranceFinancial Innovation & FintechTelecommunications & InternetInformation & Intelligence TechnologyHealthcarePharmaceuticals & Life SciencesEducation & TrainingMedia, Sports & EntertainmentNational Defense & Military IndustryRetail & Consumer ProductsIndustry & ManufacturingAgriculture & Food
-
- Latest
- Most relevant
-
-
2023-09-13
Comparison of SCC Compliance Mechanism between China and EU
This article compares the standard contract templates for cross-border transfer of data under the GDPR and in China.
-
2023-09-07
Developing and Operating Hydrogen Refueling Stations in China
The article provides an overview of China’s current legal and regulatory environment for hydrogen refueling stations.
-
2023-09-06
Outbound Investment Q&As Germany
This note aims to provide guidance for Chinese investors to invest in or acquire companies incorporated in Germany.
-
2023-08-09
China Issued Draft Personal Information Audit Measures
China issued the draft compliance audit measures to further tighten the regulation on personal information protection.
-
2023-08-08
New CDE Regulations to Boost DCT in China
CDE officially launches DCT Guildlines emphasizing patient-centricity, remote trials, and optimizing patient experience.